|
Volumn 23, Issue 1, 2013, Pages 21-28
|
Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUROLEPTIC AGENT;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
HUMAN;
HYPERLIPIDEMIA;
METABOLIC SYNDROME X;
METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
RISK FACTOR;
SCHIZOPHRENIA;
WEIGHT GAIN;
ANTIPSYCHOTIC AGENTS;
METABOLIC SYNDROME X;
METABOLISM;
SCHIZOPHRENIA;
ANTIPSYCHOTIC AGENTS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPERLIPIDEMIAS;
METABOLIC SYNDROME X;
RISK FACTORS;
SCHIZOPHRENIA;
WEIGHT GAIN;
|
EID: 84901155210
PISSN: None
EISSN: 22247041
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (32)
|
References (0)
|